MedPath
HSA Approval

ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML

SIN15057P

ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML

ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML

July 29, 2016

NATCO PHARMA ASIA PTE. LTD.

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNATCO PHARMA ASIA PTE. LTD.
Licence HolderNATCO PHARMA ASIA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION, CONCENTRATE

INTRAVENOUS

Medical Information

M05BA08

zoledronic acid

Manufacturer Information

NATCO PHARMA ASIA PTE. LTD.

Gland Pharma Limited

Active Ingredients

Zoledronic Acid Monohydrate 4.264 mg EQV Zoledronic Acid

4 mg

Zoledronic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZOLDONAT CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/5 ML - HSA Approval | MedPath